Growing Too Fast: S...
Health Care: Drugs
Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)
$76.69 -2.12 | -2.69%
02/08/12 - 04:00 PM ET
2.02M / 1.20M
Vol / Avg. Vol:78.86 / 78.81
Open / Prev. Close:75.04 - 78.86
Today's Range:42.04 - 80.97
52 Wk Range:7.26%
Performance YTD:TheStreet Rating:
Portfolios with ALXN
- Portfolio NameUser Type
- UserFinancial Machine.
- UserGFNN Stockdiagnostics
- Contributor10 Health Care Stocks to Watch
- UserIRA
- ContributorRocket Stocks for the Week ...
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Rising On Unusual Vo...
- ContributorTop-Rated Biotechnology Stocks
- ProColumbia Wanger Asset Manag...
- ContributorBreakout Stocks Of The Week...
Latest ALXN Headlines from TheStreet
- 8 Stocks Hitting 52-Week Highs: WMT, UNP, CMCSK, WCG, ALXN, AZO, AJG, IACI 02.01.12 | 02:02 pm
- Alexion Stock Hits New 52-Week High (ALXN) 02.01.12 | 09:02 am
- 10 Health Care Stocks to Watch 01.27.12 | 05:01 pm
- Alexion Stock Hits New 52-Week High (ALXN) 01.17.12 | 12:01 pm
- Alexion Shares Hit 52-Week High 01.09.12 | 10:01 am
- Alexion Reaches New 52-Week High (ALXN) 01.09.12 | 09:01 am
- 5 Rocket Stocks That Could Rally 01.09.12 | 09:01 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan (Final) 01.06.12 | 06:01 pm
- 8 Stocks Hitting New Highs Today 01.06.12 | 12:01 pm
- Cramer's 'Mad Money' Recap: Market Craves Certainty (Final) 01.04.12 | 07:01 pm
Press Releases for ALXN
- Alexion Reports Fourth Quarter And Full Year 2011 Results - Business Wire 02.09.12 | 06:02 am
- Alexion Completes Acquisition Of Enobia Pharma Corp. - Business Wire 02.07.12 | 10:02 am
- Alexion Pharmaceuticals To Report Fourth Quarter And Full Year 2011 Results On Thursday, February 9, 2012 - Business Wire 01.30.12 | 10:01 am
- Alexion To Present At The 30th Annual JP Morgan Healthcare Conference - Business Wire 01.03.12 | 10:01 am
- Alexion To Host Conference Call This Morning To Discuss Company’s Proposed Acquisition Of Enobia Pharma Corp. - Business Wire 12.29.11 | 06:12 am
- Alexion To Acquire Enobia Pharma Corp. And First Potential Treatment For Patients With Hypophosphatasia (HPP) - Business Wire 12.28.11 | 04:12 pm
- Alexion To Acquire Enobia Pharma Corp. And First Potential Treatment For Patients With Hypophosphatasia (HPP) - Business Wire 12.28.11 | 04:12 pm
- New Data Confirm Hemolysis As Predictor Of Thromboembolism And Early Death In Patients With PNH And Demonstrate Need To Test High-Risk Patients For PNH - Business Wire 12.12.11 | 01:12 pm
- Soliris® (eculizumab) Granted Marketing Authorization In Europe For Treatment Of Patients With Atypical Hemolytic Uremic Syndrome (aHUS) - Business Wire 11.29.11 | 07:11 am
- Alexion To Present At The 23rd Annual Piper Jaffray Health Care Conference - Business Wire 11.23.11 | 10:11 am
Partner Headlines for ALXN
- Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012 - Seeking Alpha 01.27.12 | 09:01 am
- Biotech Stocks On A Tear: I Like Celgene - Seeking Alpha 01.13.12 | 09:01 am
- Analyzing 5 Biotech Stocks And Their Takeover Potential - Seeking Alpha 01.13.12 | 08:01 am
- Cramer's Mad Money - 9 Things To Look For In The Coming Week (1/6/12) - Seeking Alpha 01.08.12 | 06:01 am
- Alexion Pharmaceuticals Receives Positive Mad Money/Jim Cramer Mention -CNBC - Benzinga 01.07.12 | 10:01 am
- Benzinga's Volume Gainers - Benzinga 01.06.12 | 01:01 pm
- 6 Drug Companies Favored By Hedge Funds - Seeking Alpha 01.05.12 | 09:01 am
- Recent Performance Review Of 5 Large Cap Biotech Equities - Seeking Alpha 12.27.11 | 07:12 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 12.20.11 | 09:12 am
- Alexion's Soliris EU Label Expands - Analyst Blog - Zacks 12.02.11 | 05:12 pm
